Cargando…
Immunological features of patients affected by Barraquer-Simons syndrome
BACKGROUND: C3 hypocomplementemia and the presence of C3 nephritic factor (C3NeF), an autoantibody causing complement system over-activation, are common features among most patients affected by Barraquer-Simons syndrome (BSS), an acquired form of partial lipodystrophy. Moreover, BSS is frequently as...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6954565/ https://www.ncbi.nlm.nih.gov/pubmed/31924231 http://dx.doi.org/10.1186/s13023-019-1292-1 |
_version_ | 1783486820926881792 |
---|---|
author | Corvillo, Fernando Ceccarini, Giovanni Nozal, Pilar Magno, Silvia Pelosini, Caterina Garrido, Sofía López-Lera, Alberto Moraru, Manuela Vilches, Carlos Fornaciari, Silvia Gabbriellini, Sabrina Santini, Ferruccio Araújo-Vilar, David López-Trascasa, Margarita |
author_facet | Corvillo, Fernando Ceccarini, Giovanni Nozal, Pilar Magno, Silvia Pelosini, Caterina Garrido, Sofía López-Lera, Alberto Moraru, Manuela Vilches, Carlos Fornaciari, Silvia Gabbriellini, Sabrina Santini, Ferruccio Araújo-Vilar, David López-Trascasa, Margarita |
author_sort | Corvillo, Fernando |
collection | PubMed |
description | BACKGROUND: C3 hypocomplementemia and the presence of C3 nephritic factor (C3NeF), an autoantibody causing complement system over-activation, are common features among most patients affected by Barraquer-Simons syndrome (BSS), an acquired form of partial lipodystrophy. Moreover, BSS is frequently associated with autoimmune diseases. However, the relationship between complement system dysregulation and BSS remains to be fully elucidated. The aim of this study was to provide a comprehensive immunological analysis of the complement system status, autoantibody signatures and HLA profile in BSS. Thirteen subjects with BSS were recruited for the study. The circulating levels of complement components, C3, C4, Factor B (FB) and Properdin (P), as well as an extended autoantibody profile including autoantibodies targeting complement components and regulators were assessed in serum. Additionally, HLA genotyping was carried out using DNA extracted from peripheral blood mononuclear cells. RESULTS: C3, C4 and FB levels were significantly reduced in patients with BSS as compared with healthy subjects. C3NeF was the most frequently found autoantibody (69.2% of cases), followed by anti-C3 (38.5%), and anti-P and anti-FB (30.8% each). Clinical data showed high prevalence of autoimmune diseases (38.5%), the majority of patients (61.5%) being positive for at least one of the autoantibodies tested. The HLA allele DRB1*11 was present in 54% of BSS patients, and the majority of them (31%) were positive for *11:03 (vs 1.3% allelic frequency in the general population). CONCLUSIONS: Our results confirmed the association between BSS, autoimmunity and C3 hypocomplementemia. Moreover, the finding of autoantibodies targeting complement system proteins points to complement dysregulation as a central pathological event in the development of BSS. |
format | Online Article Text |
id | pubmed-6954565 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-69545652020-01-14 Immunological features of patients affected by Barraquer-Simons syndrome Corvillo, Fernando Ceccarini, Giovanni Nozal, Pilar Magno, Silvia Pelosini, Caterina Garrido, Sofía López-Lera, Alberto Moraru, Manuela Vilches, Carlos Fornaciari, Silvia Gabbriellini, Sabrina Santini, Ferruccio Araújo-Vilar, David López-Trascasa, Margarita Orphanet J Rare Dis Research BACKGROUND: C3 hypocomplementemia and the presence of C3 nephritic factor (C3NeF), an autoantibody causing complement system over-activation, are common features among most patients affected by Barraquer-Simons syndrome (BSS), an acquired form of partial lipodystrophy. Moreover, BSS is frequently associated with autoimmune diseases. However, the relationship between complement system dysregulation and BSS remains to be fully elucidated. The aim of this study was to provide a comprehensive immunological analysis of the complement system status, autoantibody signatures and HLA profile in BSS. Thirteen subjects with BSS were recruited for the study. The circulating levels of complement components, C3, C4, Factor B (FB) and Properdin (P), as well as an extended autoantibody profile including autoantibodies targeting complement components and regulators were assessed in serum. Additionally, HLA genotyping was carried out using DNA extracted from peripheral blood mononuclear cells. RESULTS: C3, C4 and FB levels were significantly reduced in patients with BSS as compared with healthy subjects. C3NeF was the most frequently found autoantibody (69.2% of cases), followed by anti-C3 (38.5%), and anti-P and anti-FB (30.8% each). Clinical data showed high prevalence of autoimmune diseases (38.5%), the majority of patients (61.5%) being positive for at least one of the autoantibodies tested. The HLA allele DRB1*11 was present in 54% of BSS patients, and the majority of them (31%) were positive for *11:03 (vs 1.3% allelic frequency in the general population). CONCLUSIONS: Our results confirmed the association between BSS, autoimmunity and C3 hypocomplementemia. Moreover, the finding of autoantibodies targeting complement system proteins points to complement dysregulation as a central pathological event in the development of BSS. BioMed Central 2020-01-10 /pmc/articles/PMC6954565/ /pubmed/31924231 http://dx.doi.org/10.1186/s13023-019-1292-1 Text en © The Author(s). 2020 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Corvillo, Fernando Ceccarini, Giovanni Nozal, Pilar Magno, Silvia Pelosini, Caterina Garrido, Sofía López-Lera, Alberto Moraru, Manuela Vilches, Carlos Fornaciari, Silvia Gabbriellini, Sabrina Santini, Ferruccio Araújo-Vilar, David López-Trascasa, Margarita Immunological features of patients affected by Barraquer-Simons syndrome |
title | Immunological features of patients affected by Barraquer-Simons syndrome |
title_full | Immunological features of patients affected by Barraquer-Simons syndrome |
title_fullStr | Immunological features of patients affected by Barraquer-Simons syndrome |
title_full_unstemmed | Immunological features of patients affected by Barraquer-Simons syndrome |
title_short | Immunological features of patients affected by Barraquer-Simons syndrome |
title_sort | immunological features of patients affected by barraquer-simons syndrome |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6954565/ https://www.ncbi.nlm.nih.gov/pubmed/31924231 http://dx.doi.org/10.1186/s13023-019-1292-1 |
work_keys_str_mv | AT corvillofernando immunologicalfeaturesofpatientsaffectedbybarraquersimonssyndrome AT ceccarinigiovanni immunologicalfeaturesofpatientsaffectedbybarraquersimonssyndrome AT nozalpilar immunologicalfeaturesofpatientsaffectedbybarraquersimonssyndrome AT magnosilvia immunologicalfeaturesofpatientsaffectedbybarraquersimonssyndrome AT pelosinicaterina immunologicalfeaturesofpatientsaffectedbybarraquersimonssyndrome AT garridosofia immunologicalfeaturesofpatientsaffectedbybarraquersimonssyndrome AT lopezleraalberto immunologicalfeaturesofpatientsaffectedbybarraquersimonssyndrome AT morarumanuela immunologicalfeaturesofpatientsaffectedbybarraquersimonssyndrome AT vilchescarlos immunologicalfeaturesofpatientsaffectedbybarraquersimonssyndrome AT fornaciarisilvia immunologicalfeaturesofpatientsaffectedbybarraquersimonssyndrome AT gabbriellinisabrina immunologicalfeaturesofpatientsaffectedbybarraquersimonssyndrome AT santiniferruccio immunologicalfeaturesofpatientsaffectedbybarraquersimonssyndrome AT araujovilardavid immunologicalfeaturesofpatientsaffectedbybarraquersimonssyndrome AT lopeztrascasamargarita immunologicalfeaturesofpatientsaffectedbybarraquersimonssyndrome |